Research graph
References from Synthesis, characterization and in vitro cytotoxic activity of new Pt(II) complexes with trans-cinnamic acid. Local targets link to admitted publications; unresolved targets remain external evidence.
Metallodrugs are unique: opportunities and challenges of discovery and development
10.1039/d0sc04082g · 2020 · External reference
Antitumour metal compounds: more than theme and variations
10.1039/b712656p · 2008 · External reference
Inhibition of transcription by platinum antitumor compounds
10.1039/b907567d · 2009 · External reference
Platinum(IV) anticancer prodrugs - hypotheses and facts
10.1039/c6dt01414c · 2016 · External reference
Recent developments in the field of anticancer platinum complexes
10.2174/157489206777442287 · 2006 · External reference
Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches
10.2174/0929867054637626 · 2005 · External reference
Targeting and delivery of platinum-based anticancer drugs
10.1039/c2cs35259a · 2013 · External reference
Pt(II) and Pt(IV) complexes with a major component of royal jelly as innovative antitumor drug candidates
10.1039/d3nj03617k · 2023 · External reference
Platinum(IV) oxaliplatin analog containing axial benzoate ligands induces mitochondrial hyperpolarization and caspase-dependent apoptosis in pancreatic cancer cell models
10.1016/j.cbi.2025.111792 · 2026 · External reference
Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer’s disease mouse model
10.1016/j.nbd.2018.12.007 · 2019 · External reference
The occurrence, metabolism and toxicity of cinnamic acid and related compounds
10.1002/jat.2550040602 · 1984 · External reference
Cinnamic acid and cinnamaldehyde ameliorate cisplatin-induced splenotoxicity in rats
10.1002/jbt.21715 · 2015 · External reference
Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties
10.1016/j.bioorg.2019.102951 · 2019 · External reference
Cinnamic acid rescues behavioral deficits in a mouse model of traumatic brain injury by targeting miR-455-3p/HDAC2
10.1016/j.lfs.2019.116819 · 2019 · External reference
Anticancer effects of ginsenoside Rg1, cinnamic acid, and tanshinone IIA in osteosarcoma MG-63 cells: nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin
10.1016/j.biocel.2008.01.031 · 2008 · External reference
Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2 cells
10.1016/s0304-3835(98)00073-1 · 1998 · External reference
Cinnamic acid: a natural product with potential use in cancer intervention
10.1002/ijc.2910620319 · 1995 · External reference
Platinum (IV) derivatives with cinnamate axial ligands as potent agents against both differentiated and tumorigenic cancer stem rhabdomyosarcoma cells
10.1002/anie.201913996 · 2020 · External reference
A multi-action Pt IV conjugate with oleate and cinnamate ligands targets human epithelial growth factor receptor HER2 in aggressive breast cancer cells
10.1002/ange.202009491 · 2020 · External reference
Platinum(II) O,S complexes inhibit the aggregation of amyloid model systems
10.3390/ijms20040829 · 2019 · External reference
Comments on different synthetic methods for the preparation of diammine and bis(amine) organodicarboxylatoplatinum(II) complexes
10.1080/15533179308016879 · 1993 · External reference
New oxaliplatin-pyrophosphato analogs with improved in vitro cytotoxicity
10.3390/molecules26113417 · 2021 · External reference
Easily available, amphiphilic diiron cyclopentadienyl complexes exhibit in vitro anticancer activity in 2D and 3D human cancer cells through redox modulation triggered by CO release
2021 · External reference
Platinum(IV) complexes of trans-1,2-diamino-4-cyclohexene: prodrugs affording an oxaliplatin analogue that overcomes cancer resistance
10.3390/ijms21072325 · 2020 · External reference
Platinum-195 nuclear magnetic resonance
10.1016/s0010-8545(00)80523-8 · 1982 · External reference
Interactions with DNA models of the oxaliplatin analog (cis-1,3-DACH)PtCl2
10.3390/ijms25137392 · 2024 · External reference
A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring
10.1039/c9ra07760j · 2019 · External reference
Shikimic acid complexes of platinum. Preparation, reactivity, and antitumor activity of (R,R-1,2-diaminocyclohexane) bis(shikimato)platinum(II). Evidence for a novel rearrangement involving platinum—carbon bond formation
10.1016/0162-0134(91)84038-b · 1991 · External reference
Platinum, palladium, gold and ruthenium complexes as anticancer agents: current clinical uses, cytotoxicity studies and future perspectives
10.1016/j.ejmech.2017.04.007 · 2017 · External reference
A multi-action Pt IV conjugate with oleate and cinnamate ligands targets human epithelial growth factor receptor HER2 in aggressive breast cancer cells
10.1002/ange.202009491 · ExternalCitation · doi-reference
Platinum (IV) derivatives with cinnamate axial ligands as potent agents against both differentiated and tumorigenic cancer stem rhabdomyosarcoma cells
10.1002/anie.201913996 · ExternalCitation · doi-reference
Cinnamic acid: a natural product with potential use in cancer intervention
10.1002/ijc.2910620319 · ExternalCitation · doi-reference
The occurrence, metabolism and toxicity of cinnamic acid and related compounds
10.1002/jat.2550040602 · ExternalCitation · doi-reference
Cinnamic acid and cinnamaldehyde ameliorate cisplatin-induced splenotoxicity in rats
10.1002/jbt.21715 · ExternalCitation · doi-reference
Shikimic acid complexes of platinum. Preparation, reactivity, and antitumor activity of (R,R-1,2-diaminocyclohexane) bis(shikimato)platinum(II). Evidence for a novel rearrangement involving platinum—carbon bond formation
10.1016/0162-0134(91)84038-b · ExternalCitation · doi-reference
Anticancer effects of ginsenoside Rg1, cinnamic acid, and tanshinone IIA in osteosarcoma MG-63 cells: nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin
10.1016/j.biocel.2008.01.031 · ExternalCitation · doi-reference
Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties
10.1016/j.bioorg.2019.102951 · ExternalCitation · doi-reference
Platinum(IV) oxaliplatin analog containing axial benzoate ligands induces mitochondrial hyperpolarization and caspase-dependent apoptosis in pancreatic cancer cell models
10.1016/j.cbi.2025.111792 · ExternalCitation · doi-reference
Platinum, palladium, gold and ruthenium complexes as anticancer agents: current clinical uses, cytotoxicity studies and future perspectives
10.1016/j.ejmech.2017.04.007 · ExternalCitation · doi-reference
Cinnamic acid rescues behavioral deficits in a mouse model of traumatic brain injury by targeting miR-455-3p/HDAC2
10.1016/j.lfs.2019.116819 · ExternalCitation · doi-reference
Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer’s disease mouse model
10.1016/j.nbd.2018.12.007 · ExternalCitation · doi-reference
Platinum-195 nuclear magnetic resonance
10.1016/s0010-8545(00)80523-8 · ExternalCitation · doi-reference
Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2 cells
10.1016/s0304-3835(98)00073-1 · ExternalCitation · doi-reference
Antitumour metal compounds: more than theme and variations
10.1039/b712656p · ExternalCitation · doi-reference
Inhibition of transcription by platinum antitumor compounds
10.1039/b907567d · ExternalCitation · doi-reference
Targeting and delivery of platinum-based anticancer drugs
10.1039/c2cs35259a · ExternalCitation · doi-reference
Platinum(IV) anticancer prodrugs - hypotheses and facts
10.1039/c6dt01414c · ExternalCitation · doi-reference
A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring
10.1039/c9ra07760j · ExternalCitation · doi-reference
Metallodrugs are unique: opportunities and challenges of discovery and development
10.1039/d0sc04082g · ExternalCitation · doi-reference
Pt(II) and Pt(IV) complexes with a major component of royal jelly as innovative antitumor drug candidates
10.1039/d3nj03617k · ExternalCitation · doi-reference
Comments on different synthetic methods for the preparation of diammine and bis(amine) organodicarboxylatoplatinum(II) complexes
10.1080/15533179308016879 · ExternalCitation · doi-reference
Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches
10.2174/0929867054637626 · ExternalCitation · doi-reference
Recent developments in the field of anticancer platinum complexes
10.2174/157489206777442287 · ExternalCitation · doi-reference
Platinum(II) O,S complexes inhibit the aggregation of amyloid model systems
10.3390/ijms20040829 · ExternalCitation · doi-reference
Platinum(IV) complexes of trans-1,2-diamino-4-cyclohexene: prodrugs affording an oxaliplatin analogue that overcomes cancer resistance
10.3390/ijms21072325 · ExternalCitation · doi-reference
Interactions with DNA models of the oxaliplatin analog (cis-1,3-DACH)PtCl2
10.3390/ijms25137392 · ExternalCitation · doi-reference
New oxaliplatin-pyrophosphato analogs with improved in vitro cytotoxicity
10.3390/molecules26113417 · ExternalCitation · doi-reference
